TORONTO, GLIL YAM, Israel and KELOWNA, BC., April 4, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company“, “IMCannabis“, or “IMC“), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) (“Avant“) a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the “Licensing Agreement“) granting Adjupharm GmbH, IMC’s German subsidiary (“Adjupharm” or “IMC Germany“, as applicable), the exclusive right to launch the BLK MKT™ brand in the German medical cannabis market. The Licensing Agreement constitutes another major milestone with respect to the relationship between the two cannabis companies.
Under the terms of the Trademark License Agreement, Avant’s subsidiary will grant IMC Germany the license to utilize Avant’s BLK MKTTM cannabis brand for use on their…
